New research published Friday in Clinical Cancer Research magazine found that much of the common cold – yes, the one that gives you sniffles twice a year – is very able to eliminate cancer in patients of the study. The virus is called coxsackievirus, or CVA21.
Researchers from the University of Surrey and the Surrey Royal County Hospital tested the safety and “acceptability” of cold cancer viruses killed in 15 patients with non-invasive bladder cancer, known as NMIBC, a very common cancer in the UK, the cancer. state of study notification.
READ A RELATIONSHIP: Drinks are fat, fighting with obesity is the coffee in the pioneering study;
Over time, treatments for this type of bladder cancer have problems due to their invasive nature and low success rate.
For the study, catheter gave the cold virus to participants the bladder a week before their surgery was scheduled to remove their tumors.
After their surgeries, researchers found that the virus was quite selective, only focusing on cancerous cells within the organ, the loose state. The virus was also able to replicate itself and caused the cells to rupture and die. Moreover, urine samples indicated that the virus continued to attack cancer cells in the organs after all the infected cancer cells died.
After treatment, it was found that there was no cancer trace by one patient during his surgery to remove tumor. In most of the other participants, virus-driven cell death was identified, the study is held.
Hardev Pandha, the study's chief investigator, says in the release:
"Coxsackievirus could revive treatment for this type of cancer. A reduction in tumor burden and an increase in cancer cell death in all patients was observed and it removed all traces of the disease in one patient after one week of treatment, showing its effectiveness. T no significant side effects were observed in any patient. "
“Viruses have traditionally been associated with illness but in the right case they can improve our overall health and well-being by destroying cancer cells,” says Dr. Nicola Annels, researcher at the University of Surrey.
.Leave a comment